Back
ProShares UltraShort Technology Vs. ProShares UltraShort Nasdaq Biotech Industry Stock Comparison
Sell
42
REW
ProShares UltraShort Technology
Last Price:
11.23
Seasonality Move:
-8.17%
Sell
41
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
14.05
Seasonality Move:
-4.75%
Sell
42
ProShares UltraShort Technology (REW)
is a Sell
Is ProShares UltraShort Technology a Buy, Sell or Hold?
- The current ProShares UltraShort Technology [REW] share price is $12.06. The Score for REW is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- REW is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?
- The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $14.58. The Score for BIS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- BIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REW Stock Price Chart
What is ProShares UltraShort Technology's stock price today?
-
The ProShares UltraShort Technology share price today is $12.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REW is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotech's stock price today?
-
The ProShares UltraShort Nasdaq Biotech share price today is $14.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
REW Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 47.56 | Sell |
Chaikin Money Flow: | 19561 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.43 - 12.75) | Sell |
Bollinger Bands (100): | (11.32 - 13.74) | Sell |
BIS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 43.63 | Sell |
Chaikin Money Flow: | 4619 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.4 - 15.18) | Sell |
Bollinger Bands (100): | (14.77 - 17.73) | Sell |
REW Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.17 | Sell |
20-day SMA: | 12.18 | Sell |
50-day SMA: | 12.28 | Sell |
200-day SMA: | 13.82 | Sell |
8-day EMA: | 12.1 | Sell |
20-day EMA: | 12.25 | Sell |
50-day EMA: | 12.33 | Sell |
200-day EMA: | 14.6 | Sell |
BIS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.74 | Sell |
20-day SMA: | 14.73 | Sell |
50-day SMA: | 14.98 | Sell |
200-day SMA: | 17.4 | Sell |
8-day EMA: | 14.67 | Sell |
20-day EMA: | 14.82 | Sell |
50-day EMA: | 15.25 | Sell |
200-day EMA: | 17.33 | Sell |
ProShares UltraShort Technology Earnings Growth & REW Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort Technology Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProShares UltraShort Nasdaq Biotech Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |